![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 47/68 | (2017.01) |
A61K 47/6805 | (2017.08) | ||
A61P 35/00 | (2006.01) | ||
A61K 47/6811 | (2017.08) | ||
A61K 47/59 | (2017.01) | ||
A61K 47/6857 | (2017.08) | ||
A61K 47/6869 | (2017.08) | ||
A61K 47/6883 | (2017.08) | ||
A61K 47/6851 | (2017.08) | ||
A61P 35/00 | (2018.01) |
(11) | Number of the document | 3429693 |
(13) | Kind of document | T |
(96) | European patent application number | 17713127.3 |
Date of filing the European patent application | 2017-03-13 | |
(97) | Date of publication of the European application | 2019-01-23 |
(45) | Date of publication and mention of the grant of the patent | 2023-08-23 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/022155 |
Date | 2017-03-13 |
(87) | Number | WO 2017/160754 |
Date | 2017-09-21 |
(30) | Number | Date | Country code |
201662308567 P | 2016-03-15 | US | |
201662323068 P | 2016-04-15 | US | |
201662383324 P | 2016-09-02 | US |
(72) |
BERGSTROM, Donald, A. , US
BODYAK, Natalya, D. , US
LOWINGER, Timothy, B. , US
PARK, Peter, U. , US
POLING, Laura, L. , US
YURKOVETSKIY, Aleksandr, V. , US
|
(73) |
Mersana Therapeutics, Inc. ,
840 Memorial Drive, Cambridge, MA 02139,
US
|
(54) | NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF |
NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF |